This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: CBD DBD MSFT RYN SYK

NEW YORK ( TheStreet ) -- CHANGE IN RATINGS

Baxter
(BAX) was upgraded at Credit Suisse to outperform from neutral. $80 price target. Biogen Idec (BIIB) is facing delays in a competing product, and the company could split its business, Credit Suisse said.

Bristow (BRS) was upgraded to neutral at Goldman Sachs. Company is defensive and can deliver 15% to 20% annual growth, Goldman said.

Companhia Brasileira De Distribuicao (CBD) was upgraded to buy at TheStreet Ratings.

Darling (DAR) was downgraded at Wedbush to neutral from outperform. $20 price target. Estimates also cut, given lower biodiesel demand, Wedbush said.

Diebold (DBD) was upgraded at Keybanc to buy. $35 price target. Turnaround story is becoming more compelling, Keybanc said.


Hornbeck Offshore (HOS) was downgraded at Goldman Sachs to sell from neutral. $53 price target. Gulf of Mexico rig count will not grow as quickly as expected, Goldman said.

InterContinental Exchange (ICE) was upgraded at BMO Capital to outperform from market perform. $224 price target. New analyst said the company will sell Euronext and buy back shares, BMO Capital said.

Maxim (MXIM) was upgraded at MKM Partners to buy from neutral. $35 price target. Company should see better end-market demand, MKM Partners said.

Microsoft (MSFT - Get Report) was downgraded at Bank of America/Merrill Lynch to underperform. $36 price target. CEO transition adds risks to the model, BofA/Merrill said.

Nvidia NVDA was downgraded at Morgan Stanley to underweight. $13 price target. Earnings upside potential is uncertain, Morgan Stanley said.

ON Semiconductor ONNN was downgraded at MKM Partners to neutral from buy. $8 price target. Company is leveraged by a soft macro environment, MKM Partners said. 

Rayonier (RYN - Get Report) was upgraded at RBC Capital to outperform from sector perform. Real Estate business can drive earnings upside, RBC Capital said.

Stryker (SYK) was downgraded to hold at TheStreet Ratings.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
MSFT $48.24 -0.85%
RYN $25.93 0.27%
AAPL $128.70 -0.19%
FB $78.81 -0.23%
GOOG $540.78 0.54%

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs